Bank of New York Mellon Corp decreased its position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 4.7% during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results